Summary: Serum amyloid A, an apolipoprotein of high density lipoproteins, is also present to a lesser degree in low density lipoproteins and is co-localized with apolipoprotein B in atherosclerotic lesions. This study examined the effect of serum amyloid A on cellular affinity of low density lipoprotein in vitro.
Introduction
Serum amyloid A is the putative serum precursor of amyloid A, the main fibrillar constituent in reactive amyloid deposits (1, 2) . The serum amyloid A protein family in humans consists of six genetically determined isotypes (serum amyloid Αία, 1β, 1γ, 2α, 2β, and 4) (2-5). They are classified into two groups based on the regulation of their synthesis. One group are the acute phase isotypes including serum amyloid Al and 2 whose serum level is markedly increased during inflammation (2, 6) . Acute phase serum amyloid A has been proposed to be involved in several inflammatory events, such as leukocyte chemotaxis (7), induction of collagenase (8) and inhibition of platelet agglutination (9) . The other isotype, constitutive serum amyloid A (serum amyloid A4), does not behave like acute phase reactants or form amyloid fibrils (4, 10, 11) .
Serum amyloid A proteins are associated primarily with high density lipoproteins (4, 12) , and only a little with other lipoproteins in circulation (13 -15) . In inflammatory states, high density lipoprotein greatly changes its composition; increased serum amyloid A, reduced cholesterol, and reduced apolipoprotein A-I (16) . Recently, greater attention has been focussed on the roles of acute phase serum amyloid A or high density lipoproteins rich in acute phase serum amyloid A in lipoprotein metabolism. Putative biological functions include reduction of lecithin: cholesterol acyltransferase activity (17) , enhancement of the affinity of high density lipoprotein to macrophages (18) , involvement in binding cholesterol (19) , reduction of high density lipoprotein-mediated cellular cholesterol efflux (20) , and reduction of the antioxidizing effect of high density lipoprotein on low density lipoprotein (21) . Some of these activities may suggest preventative effects of acute phase serum amyloid A against atherogenesis, whereas others may suggest promotive effects. No particular function has been proposed for serum amyloid A4.
Both serum amyloid A isotypes have been detected in human atherosclerotic lesions (22) . The distribution of serum amyloid A in the lesions was identical with that of apolipoprotein B, the major protein component of low density lipoproteins. These findings led us to hypothesize that serum amyloid A bound to low density lipoprotein may affect the uptake of low density lipoprotein by the cells involved in atherogenesis. In this study, changes in cellular affinity of low density lipoprotein when loaded with serum amyloid A in vitro were investigated. Association of serum amyloid A to low density lipoprotein Recombinant serum amyloid A (100 g/1) was added to 125 I-labelled low density lipoprotein (100 g/1) to yield final concentrations of 0.1, 1, and 10 μg recombinant serum amyloid A per mg of low density lipoprotein just before cellular binding or degradation experiments. For control (referred to as 0 μg recombinant serum amyloid A per mg of low density lipoprotein), 10 μg of bovine serum albumin were added per mg of low density lipoproteins. In separate experiments to determine the amount of added recombinant serum amyloid A incorporated into low density lipoprotein, the recombinant serum amyloid A and low density lipoprotein mixture were immediately fractionated by gel filtration chromatography using consecutive columns of Superose 6 and Superose 12 (Pharmacia Biotech, Uppsala, Sweden) as previously described (15) . The amount of serum amyloid A in each fraction was measured by an enzyme-linked immunosorbent assay (10, 24) .
Materials and Methods
Oxidation of low density lipoprotein 125 I-labelled low density lipoprotein was incubated with 5 μπιοΐ/ΐ CuCl 2 for 12 hours at room temperature, and immediately used for the experiments.
Cell cultures
Human skin fibroblasts were obtained from healthy adults and maintained in fetal calf serum (volume fraction 0.1)-DMEM (Dainippon Pharmaceuticals, Osaka, Japan) at 37 °C in 5% CO 2 . Cells between passages 10 and 20 were used in experiments. Murine macrophage-like cell line J774 was obtained from the American Type Culture Collection and maintained in the same conditions as above. For determination of total cellular protein, cells were extensively washed with fetal calf serum-free DMEM, solubilized in 2 mol/1 urea, 10 mmol/1 Tris-HCl, 0.5 g/1 Tween 20, pH 8.0, and subjected to the dye-binding protein assay as above.
Cellular binding and degradation assay
Cellular binding and degradation of I25 I-labelled low density lipoprotein were determined by the method of Goldstein and Brown (25) . Confluent fibroblasts in well dishes (diametre: 5 cm) were placed in culture medium with lipoprotein-depleted fetal calf serum (volume fraction 0.1)-DMEM and maintained for 12-15 hours. For binding studies, the cells were washed with DMEM and then incubated with 1.5 ml of DMEM containing 10 mg/1 125 I-labelled low density lipoprotein (with or without serum amyloid A loading) for 2 hours at 4 °C. The cells were washed 3 times with DMEM and harvested with 100 mmol/1 NaOH. The bound radioactivity was measured in a gamma counter. For degradation studies, the cells were incubated with 20 mg/1 125 I-labelled low density lipoprotein in 2 ml of fetal calf serum (volume fraction 0.02)-DMEM for 12 hours at 37 °C in 5% CO 2 . The culture media were treated with 100 g/1 trichloroacetic acid for 30 min at 4 °C. After centrifugation, the supernatants containing trichloroacetic acid soluble 125 I-labelled degradation products were extracted with chloroform as previously described (25) and counted. Cellular binding and degradation experiments were also performed with J774 cells the same way as for fibroblasts. The data were corrected for non-specific binding or degradation obtained from an assay without cells. Results were expressed as ng bound or degraded low density lipoprotein per mg cellular proteins. All experiments were performed in triplicate. Data were analyzed using the Student's t-test.
Results

Incorporation of recombinant serum amyloid A to low density lipoprotein
Gel filtration analysis revealed that the vast majority of recombinant serum amyloid A after incubation with low density lipoprotein (1 μ § of serum amyloid A per mg of low density lipoprotein) was eluted at the position corresponding to low density lipoprotein, a little at the void volume (possibly self-aggregated forms), and negligible amounts in lower molecular mass areas ( fig. 1 ). Serum amyloid Α-loaded low density lipoproteins had the same electrophoretic mobility as normal low density lipoprotein on agarose gel electrophoresis ( fig. 1 inset) .
Binding of recombinant serum amyloid A-low density lipoprotein to fibroblasts
Both serum amyloid A isotypes associated with 125 Ilabelled low density lipoprotein increased binding of labelled low density lipoprotein to fibroblasts in a dosedependent and saturable fashion ( fig. 2 ). Binding of labelled low density lipoprotein was not effectively reduced under the presence of excess amount of non-labelled low density lipoprotein, suggesting that the enhanced binding was not receptor-mediated when recombinant serum amyloid A was on low density lipoprotein. In addition, there was no difference in competitive effects between low density lipoprotein and recombinant serum amyloid Α-loaded low density lipoprotein when added to the low density lipoprotein binding assay (fig-3 ). Binding of recombinant serum amyloid A-low density lipoprotein to J774 cells Similar to the results from the experiments on fibroblasts, both recombinant serum amyloid A isotypes increased the binding of low density lipoprotein to J774 cells in a dose-dependent and non-specific manner ( fig.  4) . Oxidized low density lipoprotein had a greater affinity for the cells than non-oxidized low density lipoprotein, and both recombinant serum amyloid A enhanced the cellular bindings of oxidized low density lipoprotein in a dose-dependent and non-specific manner ( fig. 5 ).
Effect of high density lipoprotein on the cellular bindings of recombinant serum amyloid Α-loaded low density lipoprotein The enhancement of low density lipoprotein binding to fibroblasts by both recombinant serum amyloid A isotypes was essentially abolished when high density lipoprotein isolated from a healthy subject was included in the incubation mixture of recombinant serum amyloid Α-loaded 125 I-labelled low density lipoprotein and fibroblasts ( fig. 6 ). The enhanced binding of both recombinant serum amyloid A isotype-loaded oxidized low density lipoproteins was also abolished by addition of high density lipoprotein (data not shown). When the recombinant serum amyloid Α-low density lipoprotein (1 μg of recombinant serum amyloid A per mg of low density lipoprotein) and high density lipoprotein mixtures were sity lipoprotein, the amount of degradation appeared low, suggesting that recombinant serum amyloid Α-low density lipoprotein bound to the cell surfaces was not significantly internalized. Oxidized low density lipoprotein was degraded more than native low density lipoprotein by J774 cells. Recombinant serum amyloid Al significantly increased oxidized low density lipoprotein degradation while recombinant serum amyloid A4 had no effect.
Discussion
Apolipoproteins are present on every lipoprotein particle. Although serum amyloid A is primarily associated with high density lipoproteins, a lesser association with other lipoproteins is likely. Indeed, the presence of acute phase serum amyloid A and constitutive serum amyloid A (serum amyloid A4) in low density lipoprotein from inflammatory sera and hypertriglyceridaemic sera, respectively, has been observed (13, 15) . Such conditions may be related to the promotion of the atherosclerotic diseases (26, 27) in which low density lipoproteincholesterol is accumulated in plasma and tissues. We studied the association of serum amyloid A with low density lipoprotein and its possible implications in disorders of lipoprotein metabolism.
We used human skin fibroblasts and a murine macrophage-like cell line, J774, since they have been wellstudied as low density lipoprotein receptor -and scavenger receptor -carrying cells, respectively. Recombinant proteins allowed us to examine the effects of two representative acute phase and constitutive serum amyloid A isotypes on the interaction between low density lipoprotein and cells.
The effect of recombinant serum amyloid Al or serum amyloid A4 on low density lipoprotein clearly increased binding of low density lipoprotein to both fibroblasts and J774 cells. The binding of oxidized low density lipoprotein to J774 cells was also enhanced by both recombinant serum amyloid A isotypes. When several patient sera were subjected to the same Chromatographie separation as in this study followed by serum amyloid A determinations, both serum amyloid A isotypes in the peak corresponding to low density lipoprotein were 3% of those in the high density lipoprotein peak (our unpublished observation). Thus, of the three concentrations of recombinant serum amyloid A examined, 0.1 and 1 μg serum amyloid A per mg of low density lipoprotein can occur in circulation, whereas 10 μg per mg low density lipoprotein may be rare. However, the possibility that locally synthesized serum amyloid A (28) may be associated at high concentration with low density lipoprotein cannot be ruled out.
We first speculated that serum amyloid A could alter low density lipoprotein or scavenger receptor-mediated fig. 2) , and bound recombinant serum amyloid Α-loaded low density lipoprotein were not internalized significantly into cells except for the combination of recombinant serum amyloid A1-loaded oxidized low density lipoprotein and J774 as indicated by cellular degradation experiments (tab. 1). Thus, both serum amyloid A isotypes enhance non-specific binding of low density lipoprotein to cells possibly by hydrophobic interactions, suggesting that serum amyloid A does not play an active role in low density lipoprotein metabolism in vivo. Enhanced degradation of recombinant serum amyloid A1-loaded oxidized low density lipoprotein by J774 cells was observed. Increased adsorption of oxidized low density lipoprotein to this macrophage-like cell, although non-specific, may facilitate the internalization (phagocytosis) of low density lipoprotein. The absence of a significant effect from recombinant serum amyloid A4-loaded oxidized low density lipoprotein remains to be clarified.
High density lipoprotein inhibited the effects of serum amyloid A on low density lipoprotein cellular binding by removing recombinant serum amyloid A from low density lipoprotein, due to the greater affinity of serum amyloid A for high density lipoprotein than low density lipoprotein. To date, numerous studies have used purified or recombinant serum amyloid A to elucidate functions of this protein. In some of these, high density lipoprotein was shown to abolish or reduce the experimental effects of serum amyloid A (7). It has been proposed that serum amyloid A, dissociated from high sensity lipoprotein, may produce harmful effects, such as amyloid fibril formation (11) or promotion of inflammatory reactions (7) . Serum amyloid A on low density lipoprotein may also need to be scavenged by high density lipoprotein to prevent low density lipoprotein or damaged low density lipoprotein from prolonged interactions with cells.
